145 related articles for article (PubMed ID: 15918151)
41. [A 41 year old woman with renal insufficiency and a mass in the liver].
Fernández Luque A; Urra I; López-Martos R
Med Clin (Barc); 2010 Oct; 135(11):519-26. PubMed ID: 20537360
[No Abstract] [Full Text] [Related]
42. Ruptured hepatic adenoma in liver adenomatosis: a case report of emergency surgical management.
Chiappa A; Zbar A; Audisio R; Di Palo S; Bertani E; Staudacher C
Hepatogastroenterology; 1999; 46(27):1942-3. PubMed ID: 10430373
[TBL] [Abstract][Full Text] [Related]
43. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma.
Singhi AD; Jain D; Kakar S; Wu TT; Yeh MM; Torbenson M
Am J Surg Pathol; 2012 May; 36(5):710-5. PubMed ID: 22498821
[TBL] [Abstract][Full Text] [Related]
44. [Nonalcoholic steatohepatitis: diagnosis, pathogenesis, treatment and prognosis].
Jansen PL
Ned Tijdschr Geneeskd; 2005 Feb; 149(6):289-94. PubMed ID: 15730035
[TBL] [Abstract][Full Text] [Related]
45. Non-alcoholic steatohepatitis (NASH) and hepatocellular carcinoma.
Cuadrado A; Orive A; García-Suárez C; Domínguez A; Fernández-Escalante JC; Crespo J; Pons-Romero F
Obes Surg; 2005 Mar; 15(3):442-6. PubMed ID: 15826485
[TBL] [Abstract][Full Text] [Related]
46. Hepatocellular adenomatosis presenting as prurigo.
Loze I; Tessier MH; Jumbou O; Dreno B
Br J Dermatol; 2000 Feb; 142(2):384-6. PubMed ID: 10730787
[No Abstract] [Full Text] [Related]
47. [Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease].
Kim MY; Baik SK
Korean J Hepatol; 2008 Mar; 14(1):1-3. PubMed ID: 18367852
[No Abstract] [Full Text] [Related]
48. Hepatocellular carcinoma arising from hepatocellular adenoma in a hepatitis B virus-associated cirrhotic liver.
Seo JM; Lee SJ; Kim SH; Park CK; Ha SY
Clin Radiol; 2012 Apr; 67(4):329-33. PubMed ID: 22079485
[TBL] [Abstract][Full Text] [Related]
49. [Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma].
DU JL; Wei LX; Wang YL
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):11-6. PubMed ID: 21429352
[TBL] [Abstract][Full Text] [Related]
50. [Hepatocellular adenomas and pregnancy].
Bröker ME; van Aalten SM; Ijzermans JN; Dwarkasing RS; Steegers EA; de Man RA
Ned Tijdschr Geneeskd; 2012; 156(38):A5102. PubMed ID: 22992247
[TBL] [Abstract][Full Text] [Related]
51. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out NASH.
Yoshioka Y; Hashimoto E; Yatsuji S; Kaneda H; Taniai M; Tokushige K; Shiratori K
J Gastroenterol; 2004 Dec; 39(12):1215-8. PubMed ID: 15622489
[TBL] [Abstract][Full Text] [Related]
52. Clinical presentation and management of liver adenoma hemorrhagic complications.
Lopes AG; Duarte AC
Am Surg; 2010 Jun; 76(6):654-5. PubMed ID: 20583530
[No Abstract] [Full Text] [Related]
53. Images of interest. Hepatobiliary and pancreatic: intrahepatic hemorrhage from hepatic adenoma.
Chung YF; Ooi LL
J Gastroenterol Hepatol; 2004 Jun; 19(6):710. PubMed ID: 15151630
[No Abstract] [Full Text] [Related]
54. Fatty infiltration of the liver distal to a metastatic liver tumor.
Hoshiba K; Demachi H; Miyata S; Matsui O; Takashima T; Tsuji M; Miwa A
Abdom Imaging; 1997; 22(5):496-8. PubMed ID: 9233885
[TBL] [Abstract][Full Text] [Related]
55. Coexistence of inflammatory hepatocellular adenomas with HNF1α-inactivated adenomas: is there an association?
Castain C; Sempoux C; Brunt EM; Causse O; Heitzmann A; Hernandez-Prera JC; Le Bail B; Schirmacher P; Thung SN; Balabaud C; Bioulac-Sage P
Histopathology; 2014 May; 64(6):890-5. PubMed ID: 24236804
[TBL] [Abstract][Full Text] [Related]
56. Agrin and CD34 immunohistochemistry for the discrimination of benign versus malignant hepatocellular lesions.
Tátrai P; Somorácz A; Batmunkh E; Schirmacher P; Kiss A; Schaff Z; Nagy P; Kovalszky I
Am J Surg Pathol; 2009 Jun; 33(6):874-85. PubMed ID: 19194276
[TBL] [Abstract][Full Text] [Related]
57. Nonalcoholic fatty liver disease: defining a common problem.
Gasbarrini G; Vero V; Miele L; Forgione A; Hernandez AP; Greco AV; Gasbarrini A; Grieco A
Eur Rev Med Pharmacol Sci; 2005; 9(5):253-9. PubMed ID: 16231586
[TBL] [Abstract][Full Text] [Related]
58. Steatohepatitic hepatocellular carcinoma, a morphologic indicator of associated metabolic risk factors: a study from India.
Jain D; Nayak NC; Kumaran V; Saigal S
Arch Pathol Lab Med; 2013 Jul; 137(7):961-6. PubMed ID: 23808468
[TBL] [Abstract][Full Text] [Related]
59. Nonalcoholic fatty liver disease in type 2 diabetes mellitus.
Cusi K
Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):141-9. PubMed ID: 19262374
[TBL] [Abstract][Full Text] [Related]
60. Giant hepatocellular adenoma in a child.
Ronaldi AE; Hairston FJ; Giles HW; Nowicki MJ
Dig Liver Dis; 2014 Mar; 46(3):287. PubMed ID: 24075794
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
